Literature DB >> 17881896

Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels.

Katherine E Ewings1, Ceri M Wiggins, Simon J Cook.   

Abstract

Bim (Bcl-2-interacting mediator of cell death) is a BH3-only protein (BOP), a pro-apoptotic member of the Bcl-2 protein family. The Bim mRNA undergoes alternate splicing to give rise to the short, long and extra long protein variants (Bim(S), Bim(L) and Bim(EL)). These proteins have distinct potency in promoting death and distinct modes of regulation conferred by their interaction with other proteins. Quite how Bim and other BOPs promote apoptosis has been the subject of some debate. Bim was isolated by it's interaction with pro-survival proteins such as Bcl-2 and it has been suggested that this is key to the ability of Bim to induce apoptosis. However, an alternative model argues that some forms of Bim can bind directly to the pro-apoptotic Bax and Bak proteins to initiate apoptosis. A new study may finally put this debate to rest as it provides strong evidence to suggest that Bim and other BOPs act primarily by binding to pro-survival Bcl-2 proteins, thereby releasing Bax or Bak proteins to promote apoptosis. The importance of the interaction between Bim and the pro-survival Bcl-2 proteins is underlined by our demonstration that it is regulated by ERK1/2-dependent phosphorylation of Bim(EL). ERK1/2-dependent dissociation of Bim(EL) from pro-survival proteins is the first step in a process by which the pro-survival ERK1/2 pathway promotes the destruction of this most abundant Bim splice variant. In this review we outline the significance of these new studies to our understanding of how BOPs such as Bim initiate apoptosis and how this process is regulated by growth factor-dependent signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881896     DOI: 10.4161/cc.6.18.4728

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  67 in total

1.  Perforin plays an unexpected role in regulating T-cell contraction during prolonged Listeria monocytogenes infection.

Authors:  Nathan W Schmidt; Aaruni Khanolkar; Lisa Hancox; Jonathan W Heusel; John T Harty
Journal:  Eur J Immunol       Date:  2012-01-18       Impact factor: 5.532

Review 2.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

3.  MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex.

Authors:  M Konopleva; M Milella; P Ruvolo; J C Watts; M R Ricciardi; B Korchin; T McQueen; W Bornmann; T Tsao; P Bergamo; D H Mak; W Chen; J McCubrey; A Tafuri; M Andreeff
Journal:  Leukemia       Date:  2011-11-08       Impact factor: 11.528

4.  Lipocalin 2 modulates the cellular response to amyloid beta.

Authors:  S D Mesquita; A C Ferreira; A M Falcao; J C Sousa; T G Oliveira; M Correia-Neves; N Sousa; F Marques; J A Palha
Journal:  Cell Death Differ       Date:  2014-05-23       Impact factor: 15.828

5.  The pro-apoptotic protein Bim is a microRNA target in kidney progenitors.

Authors:  Jacqueline Ho; Priyanka Pandey; Tobias Schatton; Sunder Sims-Lucas; Myda Khalid; Markus H Frank; Sunny Hartwig; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2011-05-05       Impact factor: 10.121

6.  Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression.

Authors:  C Lutz; M Mozaffari; V Tosevski; M Caj; P Cippà; B L McRae; C L Graff; G Rogler; M Fried; M Hausmann
Journal:  Clin Exp Immunol       Date:  2015-05-19       Impact factor: 4.330

7.  Paxillin confers resistance to tyrosine kinase inhibitors in EGFR-mutant lung cancers via modulating BIM and Mcl-1 protein stability.

Authors:  D-W Wu; C-Y Chen; C-L Chu; H Lee
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  Synthesis and evaluation of substituted hexahydronaphthalenes as novel inhibitors of the Mcl-1/BimBH3 interaction.

Authors:  Young B Kim; Maria E Balasis; Kenichiro Doi; Norbert Berndt; Courtney DuBoulay; Chih-Chi Andrew Hu; Wayne Guida; Hong-Gang Wang; Saïd M Sebti; Juan R Del Valle
Journal:  Bioorg Med Chem Lett       Date:  2012-07-24       Impact factor: 2.823

9.  Expression and function of bcl-2 proteins in melanoma.

Authors:  Jürgen Eberle; Amir M Hossini
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

10.  The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIM(EL).

Authors:  Y Guo; M C Schoell; R S Freeman
Journal:  Oncogene       Date:  2009-03-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.